{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T02:10:11Z","timestamp":1740363011533,"version":"3.37.3"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejmech.2025.117246","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:45:17Z","timestamp":1736037917000},"page":"117246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Radiosynthesis and evaluation of novel 18F labeled PET ligands for imaging monoacylglycerol lipase"],"prefix":"10.1016","volume":"285","author":[{"given":"Yinlong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wakana","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoteru","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Ware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsushi","family":"Kumata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhendong","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yabiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenkun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuangyan","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine Y.","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongzhao","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovic","family":"Collin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achi","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Grether","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias B.","family":"Wittwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin F.","family":"Cravatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1413-6315","authenticated-orcid":false,"given":"Steven H.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117246_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117246_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117246_bib3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1152\/physrev.00002.2016","article-title":"From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology","volume":"96","author":"Ligresti","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2025.117246_bib4","first-page":"607","article-title":"Review of the endocannabinoid system","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatr.: Cognitive Neuroscience and Neuroimaging"},{"key":"10.1016\/j.ejmech.2025.117246_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylgylcerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2025.117246_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0090-6980(00)00051-4","article-title":"Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol","volume":"61","author":"Hillard","year":"2000","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.ejmech.2025.117246_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/oxfordjournals.jbchem.a003200","article-title":"Cannabinoid receptors and their endogenous ligands","volume":"132","author":"Sugiura","year":"2002","journal-title":"J. Biochem."},{"key":"10.1016\/j.ejmech.2025.117246_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/092986607780090829","article-title":"Critical enzymes involved in endocannabinoid metabolism","volume":"14","author":"Basavarajappa","year":"2007","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ejmech.2025.117246_bib9","series-title":"Reviews of Physiology Biochemistry and Pharmacology","first-page":"1","article-title":"Endocannabinoids: synthesis and degradation","author":"Di Marzo","year":"2008"},{"key":"10.1016\/j.ejmech.2025.117246_bib10","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1039\/C4CS00047A","article-title":"Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids","volume":"43","author":"Kohnz","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2025.117246_bib11","doi-asserted-by":"crossref","first-page":"27218","DOI":"10.1074\/jbc.272.43.27218","article-title":"cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase: evolutionary relationship to esterases, lysophospholipases, and HALOPEROXIDASES","volume":"272","author":"Karlsson","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0009-3084(02)00150-0","article-title":"A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation","volume":"121","author":"Dinh","year":"2002","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejmech.2025.117246_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1748-1716.2011.02280.x","article-title":"The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors","volume":"204","author":"Savinainen","year":"2012","journal-title":"Acta Physiol."},{"key":"10.1016\/j.ejmech.2025.117246_bib14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.117246_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12013-014-9899-2","article-title":"The role of monoacylglycerol lipase (MAGL) in the cancer progress","volume":"70","author":"Qin","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2025.117246_bib16","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s41401-020-0385-7","article-title":"Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases\u2014focusing on FAAH\/MAGL inhibitors","volume":"41","author":"Ren","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117246_bib17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.apsb.2019.10.006","article-title":"Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders","volume":"10","author":"Deng","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117246_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117246_bib19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/nn1521","article-title":"Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus","volume":"8","author":"Makara","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117246_bib20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1053\/j.gastro.2012.12.028","article-title":"Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice","volume":"144","author":"Cao","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2025.117246_bib21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.celrep.2012.05.001","article-title":"A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of alzheimer's disease","volume":"1","author":"Piro","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2025.117246_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.celrep.2012.09.030","article-title":"Monoacylglycerol lipase is a therapeutic target for alzheimer's disease","volume":"2","author":"Chen","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2025.117246_bib23","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/j.1476-5381.2012.01950.x","article-title":"Monoacylglycerol lipase \u2013 a target for drug development?","volume":"166","author":"Fowler","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117246_bib24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.lfs.2012.10.025","article-title":"Therapeutic potential of monoacylglycerol lipase inhibitors","volume":"92","author":"Mulvihill","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.117246_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcp.2018.07.036","article-title":"Monoacylglycerol lipase (MAGL) as a promising therapeutic target","volume":"157","author":"Gil-Ord\u00f3\u00f1ez","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117246_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/156802608783498032","article-title":"The medicinal chemistry of agents targeting monoacylglycerol lipase","volume":"8","author":"Ortega-Gutierrez","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/13543776.2021.1841166","article-title":"An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)","volume":"31","author":"Bononi","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2025.117246_bib28","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1021\/acs.jmedchem.8b00070","article-title":"Discovery of trifluoromethyl glycol carbamates as potent and selective covalent monoacylglycerol lipase (MAGL) inhibitors for treatment of neuroinflammation","volume":"61","author":"McAllister","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib29","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1021\/acs.jmedchem.8b00951","article-title":"Identification of ABX-1431, a selective inhibitor of monoacylglycerol lipase and clinical candidate for treatment of neurological disorders","volume":"61","author":"Cisar","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib30","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/mds.28681","article-title":"Monoacylglycerol lipase inhibition in tourette syndrome: A 12-week, randomized, controlled study","volume":"36","author":"M\u00fcller-Vahl","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejmech.2025.117246_bib31","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.97.16.9226","article-title":"Positron emission tomography provides molecular imaging of biological processes","volume":"97","author":"Phelps","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117246_bib32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tips.2006.04.004","article-title":"Using positron emission tomography to facilitate CNS drug development","volume":"27","author":"Lee","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.117246_bib33","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1021\/cr0782426","article-title":"Molecular imaging with PET","volume":"108","author":"Ametamey","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117246_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrd2290","article-title":"Molecular imaging in drug development","volume":"7","author":"Willmann","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117246_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/acs.jmedchem.0c01459","article-title":"Positron emission tomography imaging of the endocannabinoid system: opportunities and challenges in radiotracer development","volume":"64","author":"Hou","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejmech.2017.04.066","article-title":"Synthesis and preclinical evaluation of [11C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL)","volume":"136","author":"Ahamed","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib37","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1021\/acs.jmedchem.8b01576","article-title":"Design, synthesis, and evaluation of (4r)-1-{3-[2-(18F)Fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one ([18F]T-401) as a novel positron-emission tomography imaging agent for monoacylglycerol lipase","volume":"62","author":"Hattori","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib38","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1021\/acs.jmedchem.1c01706","article-title":"Development of high brain-penetrant and reversible monoacylglycerol lipase PET tracers for neuroimaging","volume":"65","author":"He","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib39","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1021\/acs.jmedchem.9b00847","article-title":"Identification and development of an irreversible monoacylglycerol lipase (MAGL) positron emission tomography (PET) radioligand with high specificity","volume":"62","author":"Zhang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib40","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.1021\/acs.jmedchem.9b00936","article-title":"Design, synthesis, and evaluation of 18F-labeled monoacylglycerol lipase inhibitors as novel positron emission tomography probes","volume":"62","author":"Chen","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib41","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.apsb.2021.01.021","article-title":"Development of a highly-specific 18F-labeled irreversible positron emission tomography tracer for monoacylglycerol lipase mapping","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117246_bib42","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1021\/acs.jmedchem.7b01400","article-title":"In vitro and in vivo evaluation of 11C-labeled azetidinecarboxylates for imaging monoacylglycerol lipase by PET imaging studies","volume":"61","author":"Cheng","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib43","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.apsb.2021.07.007","article-title":"[18F]MAGL-4-11 positron emission tomography molecular imaging of monoacylglycerol lipase changes in preclinical liver fibrosis models","volume":"12","author":"Shao","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117246_bib44","doi-asserted-by":"crossref","first-page":"14283","DOI":"10.1021\/acs.jmedchem.1c00747","article-title":"Novel reversible-binding PET ligands for imaging monoacylglycerol lipase based on the piperazinyl azetidine scaffold","volume":"64","author":"Rong","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib45","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1038\/s41401-022-00912-8","article-title":"A novel monoacylglycerol lipase-targeted 18F-labeled probe for positron emission tomography imaging of brown adipose tissue in the energy network","volume":"43","author":"Cheng","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117246_bib46","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1021\/acs.jmedchem.8b01778","article-title":"Design, synthesis, and evaluation of reversible and irreversible monoacylglycerol lipase positron emission tomography (PET) tracers using a \u201ctail switching\u201d strategy on a piperazinyl azetidine skeleton","volume":"62","author":"Chen","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13550-022-00882-2","article-title":"Target occupancy study and whole-body dosimetry with a MAGL PET ligand [11C]PF-06809247 in non-human primates","volume":"12","author":"Arakawa","year":"2022","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ejmech.2025.117246_bib48","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1007\/s00259-021-05671-y","article-title":"First-in-human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with 18F-T-401","volume":"49","author":"Takahata","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2025.117246_bib49","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1021\/acs.jmedchem.1c00432","article-title":"Design and synthesis of novel spiro derivatives as potent and reversible monoacylglycerol lipase (MAGL) inhibitors: bioisosteric transformation from 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl moiety","volume":"64","author":"Ikeda","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41181-016-0016-2","article-title":"Strategies to facilitate the discovery of novel CNS PET ligands","volume":"1","author":"Zhang","year":"2016","journal-title":"EJNMMI Radiopharmacy and Chemistry"},{"key":"10.1016\/j.ejmech.2025.117246_bib51","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/anie.201805501","article-title":"Chemistry for positron emission tomography: recent advances in 11C-, 18F-, 13N-, and 15O-labeling reactions","volume":"58","author":"Deng","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117246_bib52","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/s41467-023-36377-4","article-title":"Radiochemistry for positron emission tomography","volume":"14","author":"Rong","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117246_bib53","doi-asserted-by":"crossref","first-page":"15553","DOI":"10.1002\/chem.201701581","article-title":"18F-Labeling of sensitive biomolecules for positron emission tomography","volume":"23","author":"Krishnan","year":"2017","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2025.117246_bib54","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117246_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","article-title":"P-Glycoprotein, a gatekeeper in the blood\u2013brain barrier","volume":"36","author":"Schinkel","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2025.117246_bib56","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nbt826","article-title":"Discovering potent and selective reversible inhibitors of enzymes in complex proteomes","volume":"21","author":"Leung","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2025.117246_bib57","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejmech.2012.06.043","article-title":"Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design","volume":"57","author":"Di","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117246_bib58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejps.2015.08.014","article-title":"Label-free assay for the assessment of nonspecific binding of positron emission tomography tracer candidates","volume":"79","author":"Assmus","year":"2015","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.117246_bib59","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11095-007-9517-8","article-title":"A novel design of artificial membrane for improving the PAMPA model","volume":"25","author":"Chen","year":"2008","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.ejmech.2025.117246_bib60","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/jpet.120.000158","article-title":"Calculation of an apical efflux ratio from P-glycoprotein (P-gp) in vitro transport experiments shows an improved correlation with in vivo cerebrospinal fluid measurements in rats: impact on P-gp screening and compound optimization","volume":"376","author":"Fischer","year":"2021","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117246_bib61","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/neuonc\/noaa052","article-title":"Entrectinib, a TRK\/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein","volume":"22","author":"Fischer","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2025.117246_bib62","doi-asserted-by":"crossref","first-page":"11469","DOI":"10.1021\/acs.jmedchem.9b01991","article-title":"Identification and development of a new positron emission tomography ligand 4-(2-fluoro-4-[11C]methoxyphenyl)-5-((1-methyl-1H-pyrazol-3-yl)methoxy)picolinamide for imaging metabotropic glutamate receptor subtype 2 (mGlu2)","volume":"63","author":"Yamasaki","year":"2020","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T01:30:10Z","timestamp":1740360610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342500011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":62,"alternative-id":["S022352342500011X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117246","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiosynthesis and evaluation of novel 18F labeled PET ligands for imaging monoacylglycerol lipase","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117246"}}